Benzamycin
Gastroparesis, Erythrasma, Whooping Cough + 60 more
Treatment
68 FDA approvals
20 Active Studies for Benzamycin
Treatment for
Gastroparesis
What is Benzamycin
Erythromycin
The Generic name of this drug
Treatment Summary
Erythromycin is an antibiotic used to treat bacterial infections. It was first discovered in 1952 and belongs to a family of antibiotics called macrolides. Erythromycin is effective against both gram-positive and gram-negative bacteria and can be administered in different forms such as intravenous, topical, and eye drops.
Erythrocin Stearate
is the brand name
Benzamycin Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Erythrocin Stearate
Erythromycin
1964
261
Approved as Treatment by the FDA
Erythromycin, also known as Erythrocin Stearate, is approved by the FDA for 68 uses which include Corynebacterium Infections and Urethritis .
Corynebacterium Infections
Urethritis
Postoperative Infections
urogenital infections during pregnancy
Bacterial Infections
Communicable Diseases
Respiratory Tract Infections
Listeriosis
Communicable Diseases
Whooping Cough
Amebiasis
Common Cold
Rheumatic Fever
Staphylococcal Skin Infections
Urinary Tract Infection (UTI)
Intestinal amebiasis caused by entamoeba histolytica
Corynebacterium minutissimum infection
Pneumonia
Listeria infection
Listeria monocytogenes infection
Erythrasma
Acute Otitis Media caused by Haemophilus Influenzae
Used to treat Acute Otitis Media caused by Haemophilus Influenzae in combination with Sulfisoxazole
Recurrent Upper and Lower Respiratory Tract Infections (RTIs)
Pneumonia, Mycoplasma
Streptococcus pyogenes
inflammatory papular lesions
Used to treat inflammatory papular lesions in combination with Avobenzone
prophylaxis of Rheumatic fever
treponema pallidum infection
penicillins
Upper Respiratory Tract Infection
Streptococcus Pneumoniae Infections
prophylaxis of Postoperative Infections
Whooping Cough
Bordetella Pertussis Infection
Communicable Diseases
Diphtheria
uncomplicated endocervical infection
Urethritis
Bacterial Infections
Acne Vulgaris
Used to treat predominant skin comedones, papules and pustules in combination with Tretinoin
Primary Syphilis
Corynebacterium Infections
Lower Respiratory Tract Infection (LRTI)
Ureaplasma urethritis
Staphylococcal Skin Infections
Acne Vulgaris
Used to treat Acne Vulgaris in combination with Tretinoin
diphtheria antitoxin
Communicable Diseases
Pertussis
Conjunctivitis
Skin and skin structure infections
Staphylococcus (S.) Aureus Infection
Haemophilus Influenzae Infections
Used to treat Haemophilus Influenzae Infections in combination with null
Urethritis
Legionella pneumophila
Bronchitis
Ureaplasma urealyticum
penicillins
skin and subcutaneous tissue bacterial infections caused by streptococcus pyogenes
pustular lesions
Used to treat pustular lesions in combination with Avobenzone
Whooping Cough
Chlamydia Trachomatis
patients with intolerance or contraindications to tetracycline use
Syphilis
First episode of rheumatic fever
Rheumatic Fever
Pneumococcal Infections
Sulfonamides
Effectiveness
How Benzamycin Affects Patients
Erythromycin is an antibiotic that works by stopping the growth of bacteria. It has been shown to be effective against many types of bacteria, but it is important to do a test to check if the bacteria is resistant before taking it. Taking erythromycin with sulfonamides has been shown to be effective against some strains of Haemophilus influenzae that are resistant to erythromycin alone. However, some Staphylococci may become resistant to erythromycin and/or sulfonamides during treatment. Taking erythromycin may also cause pseudomembr
How Benzamycin works in the body
Erythromycin is an antibiotic that works by preventing bacteria from making proteins. It binds to the ribosome, which processes the proteins, and stops the bacteria from producing more. This keeps the bacteria from multiplying and causes them to die, treating bacterial infections. Erythromycin works on many types of bacteria, making it a broad-spectrum antibiotic.
When to interrupt dosage
The measure of Benzamycin is dependent upon the determined sickness, including Chlamydia Trachomatis, penicillins and Syphilis. The dosage also varies as per the form of administration (e.g. Granule, for suspension or Tablet, film coated - Oral) specified in the table underneath.
Condition
Dosage
Administration
Erythrasma
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Ointment - Ophthalmic, Capsule, delayed release pellets, Capsule, delayed release, Powder, for solution, Powder, for solution - Intravenous, Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder, Capsule, delayed release pellets - Oral, Lotion, Capsule, Delayed Release, Ointment - Topical
Urethritis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Ointment - Ophthalmic, Capsule, delayed release pellets, Capsule, delayed release, Powder, for solution, Powder, for solution - Intravenous, Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder, Capsule, delayed release pellets - Oral, Lotion, Capsule, Delayed Release, Ointment - Topical
Chancroid
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Ointment - Ophthalmic, Capsule, delayed release pellets, Capsule, delayed release, Powder, for solution, Powder, for solution - Intravenous, Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder, Capsule, delayed release pellets - Oral, Lotion, Capsule, Delayed Release, Ointment - Topical
Acne Vulgaris
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Ointment - Ophthalmic, Capsule, delayed release pellets, Capsule, delayed release, Powder, for solution, Powder, for solution - Intravenous, Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder, Capsule, delayed release pellets - Oral, Lotion, Capsule, Delayed Release, Ointment - Topical
Conjunctivitis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Ointment - Ophthalmic, Capsule, delayed release pellets, Capsule, delayed release, Powder, for solution, Powder, for solution - Intravenous, Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder, Capsule, delayed release pellets - Oral, Lotion, Capsule, Delayed Release, Ointment - Topical
Listeriosis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Ointment - Ophthalmic, Capsule, delayed release pellets, Capsule, delayed release, Powder, for solution, Powder, for solution - Intravenous, Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder, Capsule, delayed release pellets - Oral, Lotion, Capsule, Delayed Release, Ointment - Topical
Acne Vulgaris
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Ointment - Ophthalmic, Capsule, delayed release pellets, Capsule, delayed release, Powder, for solution, Powder, for solution - Intravenous, Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder, Capsule, delayed release pellets - Oral, Lotion, Capsule, Delayed Release, Ointment - Topical
Acne Vulgaris
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Ointment - Ophthalmic, Capsule, delayed release pellets, Capsule, delayed release, Powder, for solution, Powder, for solution - Intravenous, Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder, Capsule, delayed release pellets - Oral, Lotion, Capsule, Delayed Release, Ointment - Topical
Endophthalmitis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Ointment - Ophthalmic, Capsule, delayed release pellets, Capsule, delayed release, Powder, for solution, Powder, for solution - Intravenous, Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder, Capsule, delayed release pellets - Oral, Lotion, Capsule, Delayed Release, Ointment - Topical
Bacterial Infections
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Ointment - Ophthalmic, Capsule, delayed release pellets, Capsule, delayed release, Powder, for solution, Powder, for solution - Intravenous, Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder, Capsule, delayed release pellets - Oral, Lotion, Capsule, Delayed Release, Ointment - Topical
Ophthalmia neonatorum (gonococcal)
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Ointment - Ophthalmic, Capsule, delayed release pellets, Capsule, delayed release, Powder, for solution, Powder, for solution - Intravenous, Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder, Capsule, delayed release pellets - Oral, Lotion, Capsule, Delayed Release, Ointment - Topical
Acne Vulgaris
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Ointment - Ophthalmic, Capsule, delayed release pellets, Capsule, delayed release, Powder, for solution, Powder, for solution - Intravenous, Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder, Capsule, delayed release pellets - Oral, Lotion, Capsule, Delayed Release, Ointment - Topical
Amebiasis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Ointment - Ophthalmic, Capsule, delayed release pellets, Capsule, delayed release, Powder, for solution, Powder, for solution - Intravenous, Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder, Capsule, delayed release pellets - Oral, Lotion, Capsule, Delayed Release, Ointment - Topical
Rheumatic Fever
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Ointment - Ophthalmic, Capsule, delayed release pellets, Capsule, delayed release, Powder, for solution, Powder, for solution - Intravenous, Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder, Capsule, delayed release pellets - Oral, Lotion, Capsule, Delayed Release, Ointment - Topical
Communicable Diseases
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Ointment - Ophthalmic, Capsule, delayed release pellets, Capsule, delayed release, Powder, for solution, Powder, for solution - Intravenous, Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder, Capsule, delayed release pellets - Oral, Lotion, Capsule, Delayed Release, Ointment - Topical
Communicable Diseases
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Ointment - Ophthalmic, Capsule, delayed release pellets, Capsule, delayed release, Powder, for solution, Powder, for solution - Intravenous, Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder, Capsule, delayed release pellets - Oral, Lotion, Capsule, Delayed Release, Ointment - Topical
Urinary Tract Infection (UTI)
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Ointment - Ophthalmic, Capsule, delayed release pellets, Capsule, delayed release, Powder, for solution, Powder, for solution - Intravenous, Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder, Capsule, delayed release pellets - Oral, Lotion, Capsule, Delayed Release, Ointment - Topical
Staphylococcal Skin Infections
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Ointment - Ophthalmic, Capsule, delayed release pellets, Capsule, delayed release, Powder, for solution, Powder, for solution - Intravenous, Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder, Capsule, delayed release pellets - Oral, Lotion, Capsule, Delayed Release, Ointment - Topical
penicillins
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Ointment - Ophthalmic, Capsule, delayed release pellets, Capsule, delayed release, Powder, for solution, Powder, for solution - Intravenous, Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder, Capsule, delayed release pellets - Oral, Lotion, Capsule, Delayed Release, Ointment - Topical
Bronchitis
, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg
, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release - Oral, Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Ointment - Ophthalmic, Capsule, delayed release pellets, Capsule, delayed release, Powder, for solution, Powder, for solution - Intravenous, Intravenous, Liquid, Liquid - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Powder - Oral, Lotion - Topical, Lotion; Swab - Topical, Lotion; Swab, Kit - Topical, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Powder, for suspension - Oral, Capsule, Delayed Release - Oral, Wafer, Wafer - Oral, Capsule, coated pellets, Capsule, coated pellets - Oral, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension - Oral, For suspension, Tablet, coated - Oral, Tablet, coated, Powder, Capsule, delayed release pellets - Oral, Lotion, Capsule, Delayed Release, Ointment - Topical
Warnings
Benzamycin has nine contraindications, so it should not be taken while experiencing the conditions delineated in the following table.
Benzamycin Contraindications
Condition
Risk Level
Notes
Severe Hypersensitivity Reactions
Do Not Combine
Erythromycin may interact with Pulse Frequency
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
Pulse Frequency
Do Not Combine
There are 20 known major drug interactions with Benzamycin.
Common Benzamycin Drug Interactions
Drug Name
Risk Level
Description
Abemaciclib
Major
The serum concentration of Abemaciclib can be increased when it is combined with Erythromycin.
Acalabrutinib
Major
The metabolism of Acalabrutinib can be decreased when combined with Erythromycin.
Alectinib
Major
The metabolism of Alectinib can be decreased when combined with Erythromycin.
Alpelisib
Major
The metabolism of Alpelisib can be decreased when combined with Erythromycin.
Aminophylline
Major
The metabolism of Aminophylline can be decreased when combined with Erythromycin.
Benzamycin Toxicity & Overdose Risk
The lowest toxic dose of erythromycin in rats has been found to be 9272mg/kg. Overdosing on erythromycin can lead to side effects such as diarrhea, nausea, stomach cramps, and vomiting. If an overdose occurs, the drug should be stopped immediately and attempts should be made to quickly remove unabsorbed drug from the system. Peritoneal dialysis or hemodialysis will not be effective in removing the drug.
Benzamycin Novel Uses: Which Conditions Have a Clinical Trial Featuring Benzamycin?
53 active investigations are currently assessing the potential of Benzamycin to treat Streptococcus pyogenes, treponema pallidum infection and Rheumatic Fever.
Condition
Clinical Trials
Trial Phases
Listeriosis
0 Actively Recruiting
Legionella pneumophila
0 Actively Recruiting
Acne Vulgaris
13 Actively Recruiting
Phase 4, Not Applicable, Early Phase 1, Phase 1, Phase 2, Phase 3
Gastroparesis
13 Actively Recruiting
Phase 3, Not Applicable, Early Phase 1
Acne Vulgaris
0 Actively Recruiting
treponema pallidum infection
0 Actively Recruiting
Corynebacterium minutissimum infection
0 Actively Recruiting
Communicable Diseases
0 Actively Recruiting
Urinary Tract Infection (UTI)
5 Actively Recruiting
Phase 1, Phase 3, Phase 4, Not Applicable
Ureaplasma urealyticum
0 Actively Recruiting
Acne Vulgaris
5 Actively Recruiting
Phase 1, Phase 2, Early Phase 1, Phase 4, Phase 3
Pneumococcal Infections
0 Actively Recruiting
Common Cold
3 Actively Recruiting
Not Applicable
Acne Vulgaris
0 Actively Recruiting
Urethritis
1 Actively Recruiting
Phase 2
penicillins
1 Actively Recruiting
Phase 3
Chlamydia Trachomatis
0 Actively Recruiting
Conjunctivitis
0 Actively Recruiting
Primary Syphilis
0 Actively Recruiting
Respiratory Tract Infections
2 Actively Recruiting
Phase 3, Not Applicable
Benzamycin Reviews: What are patients saying about Benzamycin?
5
Patient Review
4/6/2008
Benzamycin for Acne
5
Patient Review
1/27/2013
Benzamycin for Acne
5
Patient Review
10/30/2017
Benzamycin for Acne
4.7
Patient Review
12/2/2007
Benzamycin for Acne
3.7
Patient Review
9/21/2007
Benzamycin for Acne
2.7
Patient Review
5/7/2010
Benzamycin for Acne
Patient Q&A Section about benzamycin
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What kind of patient would get Benzamycin?
"This medication is used to treat acne. It may be used alone or with other medications. It belongs to a class of drugs called topical acne agents. It is not known if this drug is safe and effective in children younger than 12 years of age."
Answered by AI
How long does it take Benzamycin to work?
"If you stop using this product, your acne may come back.
If you discontinue use of this product, your acne may worsen."
Answered by AI
Is Benzamycin good for acne?
"Benzamycin is a topical combination medication that works well to treat acne. It contains erythromycin and benzoyl peroxide, which work together to kill acne-causing bacteria and reduce inflammation."
Answered by AI
What is Benzamycin gel used for?
"Benzamycin is a combination of erythromycin, an antibiotic, and benzoyl peroxide, a medication with antibacterial and mild drying properties. It is used to treat acne."
Answered by AI